Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN An

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 18, 2024--

Related Keywords

Canada , California , United States , United Kingdom , Italy , Milan , Lombardia , London , City Of , Foster City , Lorenzo Dantiga , Intrahepatic Cholestasis , Jolan Terner Rosenthal , Erin Murphy , Richardj Thompson , Andrew Mckibben , European Commission , Linkedin , King College London , King College , Liver Health , Drug Administration , Nasdaq , Mirum Pharmaceuticals Inc , Instagram , European Society For Paediatric , Health Canada , European Society , Annual Meeting , Progressive Familial Intrahepatic Cholestasis , Pam Vig , Long Term Maintenance , Improved Liver Health , Data From , Plenary Session , Hepatology Highest Scoring , Professor Richard , College London , Maralixibat Leads , Significant Reductions , Lorenzod Antiga , Papa Giovanni , Maralixibat Impact , Concomitant Medication Use , Cholestatic Pruritus , Alagille Syndrome , Mirum Pharmaceuticals , Significant Improvements , Genetic Diagnosis , Progressive Familial Intrahepatic Cholestasis Due , Improved Quality , Maralixibat Can Improve Cholestatic Pruritus , Surgical Biliary Diversion , Breakthrough Therapy , Fat Soluble Vitamin , Media Contact , Business Wire ,